TwitterFacebookLinkedIn

Global Patient Perspectives Roundtable
Navigating Telehealth/Telemedicine & Embracing Shared Decision-Making

Saturday, November 21, 2020
9:00 – 10:30 am CST | 3:00 – 4:30 pm UTC
See more time zones.

Register Here

Registration is free but required.

This Global Patient Perspectives Roundtable—focused on Telehealth/Telemedicine and Shared Decision-Making—is the first in a series of four roundtables sponsored by GSK. These topics are relevant to patient care and outcomes, options, and autonomy and are especially significant in the backdrop of COVID-19 and of global discussions of health equity. Participating in this active exchange of information across populations, specialties, and regions, attendees will enhance their understanding of these important topics and be more empowered to exercise their rights and options related to each.

Moderator

Daniela Luvero
Member, IGCS Council
Gynecologic Oncologist, University Campus Bio Medico of Rome
Italy

 

Panelists

Gwen Darien
Executive Vice President, Patient Advocacy & Engagement, National Patient Advocate Foundation & Patient Advocate Foundation, USA

 

Miriam Mutebi
Breast Surgical Oncologist & Assistant Professor of Surgery, Aga Khan University Hospital
Kenya

 

Karen Begaii-Wilson
Cervical Cancer Survivor & Advocate
Navajo Nation
USA

Noriko Fujiwara
Oncology & Research Nurse
IMSUT Hospital of the Institute of Medical Science, University of Tokyo
Japan

 

Graziela Zibetti Dal Molin
Medical Oncologist
Beneficência Portuguesa de São Paulo Hospital
Brazil

 

Kimlin Ashing
Professor & Founding Director, Center of Community Alliance for Research & Education, City of Hope National Medical Center
USA

About the IGCS Patient Perspectives Roundtable Series
During the COVID-19 pandemic and in its aftermath, IGCS will continue to be a global source of education and resources, training, public awareness, and advocacy. Virtual Roundtables will

  • facilitate first-hand assessment of patient community needs and concerns
  • provide vetted information, assessments, and guidance from key opinion leaders and seasoned survivors/advocates
  • address current patient and wider community concerns through live responses to question posted online during the session
  • promote strategic conversations with health care and research communities around specific issues
  • assist all in coming to workable solutions and strategies for moving forward during the COVID-19 pandemic and in its aftermath

Each 60- to 90-minute session will cover a specific topic important to the gynecologic cancer patient communities maneuvering through the health and cancer care system during and after COVID-19 and will include IGCS key opinion leaders, patients-caregivers, and other stakeholders appropriate to the topic.